HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Hiromatsu Selected Research

Kaposi Varicelliform Eruption (Eczema Herpeticum)

12/2018Loss of ATP2A2 Allows Herpes Simplex Virus 1 Infection of a Human Epidermis Model by Disrupting Innate Immunity and Barrier Function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Hiromatsu Research Topics

Disease

7Infections
01/2023 - 08/2003
5Tuberculosis (Tuberculoses)
06/2011 - 07/2002
3COVID-19
11/2023 - 01/2022
2Breakthrough Infections
01/2024 - 11/2023
2Communicable Diseases (Infectious Diseases)
07/2022 - 12/2019
2Persistent Infection
07/2022 - 08/2004
2Inflammation (Inflammations)
02/2021 - 07/2004
2Hypersensitivity (Allergy)
06/2011 - 05/2011
2Autoimmune Diseases (Autoimmune Disease)
01/2003 - 06/2002
1Metabolic Diseases (Metabolic Disease)
01/2023
1Metaplasia
09/2022
1Bacteremia
04/2022
1Respiratory Syncytial Virus Infections
01/2022
1Post-Acute COVID-19 Syndrome
01/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2022
1Chorioamnionitis
02/2021
1Chlamydophila Infections
01/2020
1Kaposi Varicelliform Eruption (Eczema Herpeticum)
12/2018
1Human Influenza (Influenza)
01/2017
1Pseudomonas Infections
06/2015
1Pancreatic Fistula (Pancreatic Fistulas)
06/2015
1Infection with Mycobacterium marinum
06/2013
1Urinary Bladder Neoplasms (Bladder Cancer)
08/2012
1Neoplasms (Cancer)
08/2012
1Latent Infection
06/2011
1Latent Tuberculosis
06/2011
1Septic Shock (Toxic Shock Syndrome)
05/2010
1Ileus
01/2008
1Hemorrhage
01/2008
1Strongyloidiasis
01/2008
1Toxocariasis
01/2007
1Visceral Larva Migrans
01/2006
1Nematode Infections
08/2004
1Colitis
07/2004
1Eosinophilia
05/2004
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2003

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2019 - 06/2002
4LipidsIBA
06/2011 - 07/2002
3VaccinesIBA
01/2024 - 08/2003
3Immunoglobulin G (IgG)IBA
01/2024 - 01/2006
3AntigensIBA
05/2011 - 01/2003
2Messenger RNA (mRNA)IBA
11/2023 - 08/2004
2Fatty Acid-Binding ProteinsIBA
01/2023 - 01/2020
2DipeptidesIBA
07/2022 - 12/2019
2GlycolipidsIBA
05/2011 - 07/2002
1Immunoglobulin A (IgA)IBA
01/2024
1Immunoglobulins (Immunoglobulin)IBA
11/2023
1N- (2- (2- (4- chlorophenyl)- 1,3- thiazol- 4- yl)ethyl)butanamideIBA
01/2023
1zinc chlorideFDA Link
09/2022
1Therapeutic UsesIBA
07/2022
1Boron CompoundsIBA
07/2022
1Bortezomib (Velcade)FDA Link
07/2022
1COVID-19 VaccinesIBA
05/2022
1BNT162 VaccineIBA
05/2022
1beta-LactamsIBA
04/2022
1Angiotensin-Converting Enzyme 2IBA
01/2022
1Serine Proteases (Serine Protease)IBA
01/2022
1Glycoproteins (Glycoprotein)IBA
01/2022
1MicroRNAs (MicroRNA)IBA
02/2021
1Biomarkers (Surrogate Marker)IBA
02/2021
1Ribosomal DNA (rDNA)IBA
02/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020
1MitoTEMPOIBA
01/2020
1Serine (L-Serine)FDA Link
01/2019
1Adenosine Triphosphate (ATP)IBA
01/2019
115- methyl- 8- aza- 16- oxagona- 1,3,5(10),13- tetraen- 17- one (MAOTO)IBA
01/2017
1TrypsinogenIBA
06/2015
1Calcitriol (Calcijex)FDA LinkGeneric
06/2013
1Vitamin DFDA LinkGeneric
06/2013
1CathelicidinsIBA
06/2013
1Aquaporins (Water Channels)IBA
08/2012
1Proteasome Endopeptidase Complex (Proteasome)IBA
08/2012
1DNA (Deoxyribonucleic Acid)IBA
08/2012
1DNA VaccinesIBA
08/2012
1UbiquitinIBA
08/2012
1glycerol monomycolateIBA
06/2011
1CytokinesIBA
05/2011
1Tuberculin (PPD)IBA
05/2011
1Interferon-gamma (Interferon, gamma)IBA
05/2010
1SteroidsIBA
01/2008
1Ivermectin (Mectizan)FDA Link
01/2008
1Interleukin-5 (Interleukin 5)IBA
08/2004
1Interleukin-4 (Interleukin 4)IBA
08/2004
1Eosinophil PeroxidaseIBA
08/2004
1Sulfonic AcidsIBA
07/2004
1Transforming Growth Factor beta (TGF-beta)IBA
07/2004
1sym-trinitrobenzeneIBA
07/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2004
1Interleukin-15 (Interleukin 15)IBA
07/2004
1Immunoglobulin E (IgE)IBA
05/2004
1AerosolsIBA
08/2003
1Liposomes (Liposome)IBA
08/2003

Therapy/Procedure

7Therapeutics
09/2022 - 02/2003
1Pancreaticoduodenectomy
06/2015
1Enteral Nutrition (Feeding, Tube)
05/2010
1Total Parenteral Nutrition
05/2010
1Aftercare (After-Treatment)
01/2008
1Enema (Enemas)
01/2008
1Colonic Pouches (S Pouch)
01/2007
1Cell- and Tissue-Based Therapy (Cell Therapy)
07/2004